202 related articles for article (PubMed ID: 18283864)
1. [Transfusion-transmitted diseases].
Shimoyama R
Hokkaido Igaku Zasshi; 2008 Jan; 83(1):5-21. PubMed ID: 18283864
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-transmitted infections: existing and emerging pathogens.
Kaur P; Basu S
J Postgrad Med; 2005; 51(2):146-51. PubMed ID: 16006714
[TBL] [Abstract][Full Text] [Related]
3. Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections.
Tani Y; Aso H; Matsukura H; Tadokoro K; Tamori A; Nishiguchi S; Yoshizawa H; Shibata H;
Vox Sang; 2012 May; 102(4):285-93. PubMed ID: 22082342
[TBL] [Abstract][Full Text] [Related]
4. Emerging issues in blood safety.
Chamberland M; Khabbaz RF
Infect Dis Clin North Am; 1998 Mar; 12(1):217-29. PubMed ID: 9494840
[TBL] [Abstract][Full Text] [Related]
5. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
[TBL] [Abstract][Full Text] [Related]
6. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
Corash L
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
[TBL] [Abstract][Full Text] [Related]
7. [Risks to donor and recipient in blood collection and blood transfusion].
Bergmann H
Infusionsther Klin Ernahr; 1977 Apr; 4(2):84-6. PubMed ID: 558163
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-transmitted infectious diseases.
Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
[TBL] [Abstract][Full Text] [Related]
9. Approaches to minimize infection risk in blood banking and transfusion practice.
Lindholm PF; Annen K; Ramsey G
Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
Koch C; Araújo F
Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
[TBL] [Abstract][Full Text] [Related]
11. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
12. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
[TBL] [Abstract][Full Text] [Related]
13. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
14. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
Pillonel J; Laperche S; ; ;
Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
[TBL] [Abstract][Full Text] [Related]
15. Reacting to an emerging safety threat: West Nile virus in North America.
Stramer SL
Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880
[TBL] [Abstract][Full Text] [Related]
16. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
17. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
18. Prevention of infections transmissible by blood derivatives.
Barbara JA
Transfus Sci; 1998 Mar; 19(1):3-7. PubMed ID: 10182180
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-transmitted infections.
Bihl F; Castelli D; Marincola F; Dodd RY; Brander C
J Transl Med; 2007 Jun; 5():25. PubMed ID: 17553144
[TBL] [Abstract][Full Text] [Related]
20. [Update on infectious risks associated with blood products].
Traineau R; Elghouzzi MH; Bierling P
Rev Prat; 2009 Jan; 59(1):86-9. PubMed ID: 19253889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
